Understanding Quality Paradigm Shifts in the Evolving Pharmaceutical Landscape: Perspectives from the USP Quality Advisory Group (original) (raw)

Saudi Pharmaceutical Journal, 2014

Advancing pharmaceutical quality: An overview of science and research in the U.S. FDA's Office of Pharmaceutical Quality

Daniel Harris

International journal of pharmaceutics, 2016

View PDFchevron_right

Advancing Product Quality: a Summary of the Second FDA/PQRI Conference

Gk Raju

The AAPS journal, 2016

View PDFchevron_right

Understanding Industrial Practices for Pharmaceutical Quality Management- I, Existing Approaches and Guidelines

Ashish Baldi

2015

View PDFchevron_right

Quality in the pharmaceutical industry – A literature review

reham haleem

Journal of The Saudi Pharmaceutical Society, 2015

View PDFchevron_right

Advancing Product Quality: a Summary of the Inaugural FDA/PQRI Conference

Gk Raju

The AAPS journal, 2015

View PDFchevron_right

A Brief Review of FDA’s Novel Tools for Ensuring Pharmaceutical Quality in the Human Drug Supply Chain

Robert Lodder

2021

View PDFchevron_right

Quality by design (QbD) approaches in current pharmaceutical set-up

sourav singh

Expert opinion on drug delivery, 2018

View PDFchevron_right

A Review of Total Quality Management in Pharmaceutical Industries

Dhwani Bhavsar

2022

View PDFchevron_right

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE QUALITY RISK MANAGEMENT Q9

Alexis Lema

View PDFchevron_right

Understanding pharmaceutical quality by design

Gk Raju

The AAPS journal, 2014

View PDFchevron_right

An overview of established practices and parameters to ensure quality of a pharmaceutical product

Shimu Akter

2017

View PDFchevron_right

Total Quality Management of Pharmaceuticals: Recent Approaches and Advancements

Ashish Baldi

2014

View PDFchevron_right

Quality Risk Management Approach for Drug Development and Its Future Prospectives

Muthukumar Subramanian

Journal for Research in Applied Sciences and Biotechnology

View PDFchevron_right

FDA Approaches in Monitoring Drug Quality, Forces Impacting the Drug Quality, and Recent Alternative Strategies to Assess Quality in the US Drug Supply

Billie Mitchell

Journal of Pharmaceutical Innovation

View PDFchevron_right

QbD Approach: A Framework for Integrating Quality into Pharmaceutical Products

Kamal Singh Rathore

Journal of Pharmaceutical Research International, 2022

View PDFchevron_right

A new definition of pharmaceutical quality: Assembly of a risk simulation platform to investigate the impact of manufacturing/product variability on clinical performance

James Drennen

Journal of Pharmaceutical Sciences, 2010

View PDFchevron_right

Emerging Achivements of Quality by Design in Pharmaceutical Industry

BASU VENKATESWARA REDDY

2019

View PDFchevron_right

Quality Risk Management in Pharmaceutical Industries

Fauziya Khan

International Journal of Research in Pharmacy and Chemistry, 2020

View PDFchevron_right

Pharmaceutical Quality by Design: A New Approach in Product Development

ashwini gawade

Research & Reviews: Journal of Pharmacy and Pharmaceutical Sciences, 2013

View PDFchevron_right

Factors to consider in developing individual pharmaceutical product quality risk profiles useful to government procurement agencies

Garth Boehm

Acta pharmaceutica Sinica. B, 2016

View PDFchevron_right

Quality by Design (QbD): An Emerging Trend in Improving Quality and Development of Pharmaceuticals

Alpana Asnani

Saudi Journal of Medical and Pharmaceutical Sciences, 2019

View PDFchevron_right

Pharmaceutical Quality-by-Design (QbD): Basic Principles

Shilpa Bhilegaonkar

2020

View PDFchevron_right

Quality control and assurance from the development to the production of biopharmaceuticals

rudolf bliem

Trends in Biotechnology, 1999

View PDFchevron_right

Pharmaceutical product development: A quality by design approach

Naseem Charoo

International journal of pharmaceutical investigation

View PDFchevron_right

Effective Management of Post-Approval Changes in the Pharmaceutical Quality System (PQS):Through Enhanced Science and Risk-Based Approaches Changes to Analytical Equipment/Instrumentation that are Deemed Equivalent

Emma Ramnarine

2020

View PDFchevron_right

Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design (QbD) and Process Analytical Technology (PAT)

Jarkko Ketolainen, Wim Oostra

European Journal of Pharmaceutical Sciences, 2012

View PDFchevron_right

Guidance for Industry Q10 Pharmaceutical Quality System

Dr Raja Roy Choudhury

International Journal of Research in Commerce & Management, 2017

View PDFchevron_right

DemonstratingPharmaceutical Quality System Effectiveness and Driving Continual Improvement:Evidence-BasedRisk Reduction

Emma Ramnarine

PDA Journal of Pharmaceutical Science and Technology

View PDFchevron_right

Risk-based Quality by Design (QbD): A Taguchi Perspective on the Assessment of Product Quality, and the Quantitative Linkage of Drug Product Parameters and Clinical Performance

James Drennen

Journal of Pharmaceutical Innovation, 2008

View PDFchevron_right

Understanding Quality Paradigm Shifts in the Evolving Pharmaceutical Landscape: Perspectives from the USP Quality Advisory Group (original) (raw)

Related papers